These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 23002976

  • 1. Influenza vaccines: T-cell responses deserve more attention.
    Schotsaert M, Saelens X, Leroux-Roels G.
    Expert Rev Vaccines; 2012 Aug; 11(8):949-62. PubMed ID: 23002976
    [Abstract] [Full Text] [Related]

  • 2. Cellular immune responses to recurring influenza strains have limited boosting ability and limited cross-reactivity to other strains.
    Keynan Y, Card CM, Ball BT, Li Y, Plummer FA, Fowke KR.
    Clin Microbiol Infect; 2010 Aug; 16(8):1179-86. PubMed ID: 20670292
    [Abstract] [Full Text] [Related]

  • 3. Longitudinal and integrative biomodeling of effector and memory immune compartments after inactivated influenza vaccination.
    Bonduelle O, Yahia N, Siberil S, Benhabiles N, Carrat F, Krivine A, Rozenberg F, Dimitrov J, Kaveri SV, Curjol A, Tindel M, Louet M, Desert F, Launay O, Loulergue P, Badre G, Katlama C, Bricaire F, Samri A, Rousset D, van der Werf S, Jauréguiberry S, Combadiere B.
    J Immunol; 2013 Jul 15; 191(2):623-31. PubMed ID: 23776176
    [Abstract] [Full Text] [Related]

  • 4. Humoral and cellular immune responses in children given annual immunization with trivalent inactivated influenza vaccine.
    Zeman AM, Holmes TH, Stamatis S, Tu W, He XS, Bouvier N, Kemble G, Greenberg HB, Lewis DB, Arvin AM, Dekker CL.
    Pediatr Infect Dis J; 2007 Feb 15; 26(2):107-15. PubMed ID: 17259871
    [Abstract] [Full Text] [Related]

  • 5. Influenza viruses and cross-reactivity in healthy adults: humoral and cellular immunity induced by seasonal 2007/2008 influenza vaccination against vaccine antigens and 2009 A(H1N1) pandemic influenza virus.
    Iorio AM, Bistoni O, Galdiero M, Lepri E, Camilloni B, Russano AM, Neri M, Basileo M, Spinozzi F.
    Vaccine; 2012 Feb 21; 30(9):1617-23. PubMed ID: 22245606
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Intranasal lipopeptide primes lung-resident memory CD8+ T cells for long-term pulmonary protection against influenza.
    Deliyannis G, Kedzierska K, Lau YF, Zeng W, Turner SJ, Jackson DC, Brown LE.
    Eur J Immunol; 2006 Mar 21; 36(3):770-8. PubMed ID: 16435281
    [Abstract] [Full Text] [Related]

  • 8. Establishment of functional influenza virus-specific CD8(+) T cell memory pools after intramuscular immunization.
    Wang Z, Chua BY, Ramos JV, Parra SM, Fairmaid E, Brown LE, Jackson DC, Kedzierska K.
    Vaccine; 2015 Sep 22; 33(39):5148-54. PubMed ID: 26277069
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Virus-specific T cells as correlate of (cross-)protective immunity against influenza.
    Altenburg AF, Rimmelzwaan GF, de Vries RD.
    Vaccine; 2015 Jan 15; 33(4):500-6. PubMed ID: 25498210
    [Abstract] [Full Text] [Related]

  • 11. A prospective, randomized, open-label trial comparing the safety and efficacy of trivalent live attenuated and inactivated influenza vaccines in adults 60 years of age and older.
    Forrest BD, Steele AD, Hiemstra L, Rappaport R, Ambrose CS, Gruber WC.
    Vaccine; 2011 May 09; 29(20):3633-9. PubMed ID: 21440036
    [Abstract] [Full Text] [Related]

  • 12. Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine.
    Belshe R, Lee MS, Walker RE, Stoddard J, Mendelman PM.
    Expert Rev Vaccines; 2004 Dec 09; 3(6):643-54. PubMed ID: 15606348
    [Abstract] [Full Text] [Related]

  • 13. Immunogenicity and safety of a quadrivalent live attenuated influenza vaccine in children.
    Block SL, Falloon J, Hirschfield JA, Krilov LR, Dubovsky F, Yi T, Belshe RB.
    Pediatr Infect Dis J; 2012 Jul 09; 31(7):745-51. PubMed ID: 22466322
    [Abstract] [Full Text] [Related]

  • 14. Pediatric influenza vaccination: understanding the T-cell response.
    Bodewes R, Fraaij PL, Osterhaus AD, Rimmelzwaan GF.
    Expert Rev Vaccines; 2012 Aug 09; 11(8):963-71. PubMed ID: 23002977
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. HI responses induced by seasonal influenza vaccination are associated with clinical protection and with seroprotection against non-homologous strains.
    Luytjes W, Enouf V, Schipper M, Gijzen K, Liu WM, van der Lubben M, Meijer A, van der Werf S, Soethout EC.
    Vaccine; 2012 Jul 27; 30(35):5262-9. PubMed ID: 22691431
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection.
    Schmidt T, Dirks J, Enders M, Gärtner BC, Uhlmann-Schiffler H, Sester U, Sester M.
    Eur J Immunol; 2012 Jul 27; 42(7):1755-66. PubMed ID: 22585549
    [Abstract] [Full Text] [Related]

  • 19. Mucosal IgA responses in influenza virus infections; thoughts for vaccine design.
    van Riet E, Ainai A, Suzuki T, Hasegawa H.
    Vaccine; 2012 Aug 31; 30(40):5893-900. PubMed ID: 22835738
    [Abstract] [Full Text] [Related]

  • 20. Cellular immune responses to influenza.
    Moss P.
    Dev Biol (Basel); 2003 Aug 31; 115():31-7. PubMed ID: 15088773
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.